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Principles of Minireview
Viral Pathogenesis
Michael B. A. Oldstone, M. D. This ignorance of pathogenic mechanisms is not unique
to poliovirus. Equally obscure is how HIV causes dementiaThe Scripps Research Institute
Division of Virology and immunosuppressionand why measlesvirus promotes
generalized immunosuppression, and so on.Department of Neuropharmacology
10550 N. Torrey Pines Road Much of our existing knowledge of viral pathogenesis
has come from experimental studies using animal mod-La Jolla, California 92037
els of virus–host interactions. Often the principles de-
rived have provided universal concepts that proved ap-
plicable to human diseases. Perhaps the best examples
Patho is derived from the Greek pa´uos, meaning suffer- are reovirus (reviewed by Nibert etal., 1991) and lympho-
ing or disease, and genesis from the Greek ge´vesis, cytic choriomeningitis virus (LCMV; reviewed by Borrow
which translates “to come into being or origin.” Viral
and Oldstone, 1996) infections of the mouse. Mamma-
pathogenesis, then, is defined as “how viruses produce lian reoviruses are non-enveloped viruses that have a
disease in the host.” The portrait of viral pathogenesis genome consisting of 10 segments of double-stranded
is the sum of functions through which a virus causes RNA. Although this virus has not yet been linked to
disease (virulence) and the host resists or is susceptible. any severe disease of humans, manipulation of reovirus
Despite the avalanche of knowledge concerning viral genes in mice successfully illustrates the overall strate-
gene structure and function, and the ability to manipu- gies viruses use in binding to and entering primary cells
late both cultured cells and animal models genetically, and in replicating, growing, and spreading to secondary
our understanding of how viruses cause disease is target organs in vivo. Such studies indicate that reovir-
scanty. As an example, for poliovirus, despite the wealth uses can be considered as a general model for many
of information on its molecular structure, control of gene other viruses that undoubtedly use similar pathways and
regulation including the details of its replication, tran- principles. The beauty of this model is that the viral
scription, translation, and assembly, the solving of its genes and their products can be defined at each step
three-dimensional structure, the discovery of its recep- of viral binding to cells, entry, replication, and spread
tor, and the availability of a transgenic model, our knowl- in the animal host, as can their interactions with the
edge of how poliovirus actually causes poliomyelitis is host’s immune system.
limited. Considering thenumber of persons infected with LCMV is a negative-strand, ambisense virus having
the virus, few develop poliomyelitis. In 1955, when an two RNA segments. Analysis of the parameters defining
outbreak of poliomyelitis followed the use of a formalde- acute LCMV infection has led to the initial observations
hyde-inactivated poliovirus vaccine, of the 120,000 chil- that T lymphocytes are a major controlling factor of
dren inoculated with the improperly inactivated lots of many viral (and other infectious)diseases, MHC compat-
polio type 1, approximately 60,000 (or 50%) were sus- ibility is required for activation of cytotoxic T lympho-
ceptible to the infection in that they had no evidence of cytes (CTL) and their recognition of infected cells (an
preexisting immunity. Yet,of those 60,000, only between observation that was rewarded with this year’s Nobel
600 and 1500 became infected, as evident by minor Prize in Medicine and Physiology) and MHC diversity is
clinical findings and/or fecal excretion of virus, and favorable in the battle against infectious agents (Zinker-
fewer than 0.1% (or 60 patients) developed paralytic nagel and Doherty, 1979). Similarly, a number of the
polio. Still unknown is why fewer than 1% of people who defining pathogenic events associated with DNA and
encounter poliovirus for the first time get the disease, RNA viruses that persist in humans have also been es-
compared to greater than 99% who become ill after tablished and/or clarified from the study of LCMV infec-
infection by measles virus. Thus, the determinants that tion in its natural murine host. Examples include the
control viral virulence or host susceptibility (or resis- recognition that viral persistence most often requires
tance) in the natural host are far from being understood replication of the virus in cells (lymphocytes, dendritic
in terms of molecules or genes involved. macrophages) of the immune system and that antiviral
Yet, for poliovirus, the pathologic consequences of antibodies interact with the virus or its antigens to form
acute and limited infection in vivo are rather easy to virus–antibody immune complexes. Not only are these
follow. Polioviruses reach the central nervous system immune complexes markers of persistent infection but
anterior horn cells in susceptible individuals during the they also cause the vasculitis (deposition of immune
first week of infection. These cells are destroyed within complexes in arteries), glomerulonephritis (deposition
hours and, if enough are affected, muscles become par- of immune complexes in the renal glomeruli), and mental
alyzed as the characteristic disease progresses. Why confusion (deposition of immune complexes in the
poliovirus has such a high affinity for anterior horn neu- brain’s choroid plexus) that accompany many, if not all,
rons but not other types of neurons in the central ner- persistent infections.
vous system is not understood, nor is it known why, Unlike the relatively short-lived acute infections, per-
when most cells presumably express poliovirus recep- sistent virus infections offer an opportunity for pro-
tors, only neuronal cellsand perhapscells of the lympho- longed pathologic consequences. But how do viruses
persist? What are the molecular determinants, how doreticular system become infected.
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they damage tissue, and what kind of disease(s), in addi- post-infection with the wild-type strain, viruses with the
Phe to Leu change are found in murine recipients’tion to immune complexes, can they cause?
Viruses that persist must first devise a strategy to spleens, lymph nodes, and macrophages. In contrast,
the Phe marker does not change in infected neuronsremain within cells for a prolonged period of time without
disturbing the transcription or translation of the genes even at one year post-infection. Selective competition
both in vitro and in vivo (Dockter et al., 1996) favors thenecessary for the infected cells’ survival. Also, such
viruses must not alter lysosomal or plasma membranes wild-type strain over Clone 13 for neuronal replication.
However, more efficient replication of Clone 13 than ofor cytoskeletal structures of the infected cells. Second,
viruses must escape immune surveillance. Since the the wild-type in antigen presenting cells and splenic
lymphocytes suggests that unique cellular transcriptionCTL is the major player in discriminating self (host anti-
gens) from foreign (viral antigens), viruses need to evade factors are likely to play a role in selection of one virus
species over another and illustrates the need to studyrecognition by CTL. Most often this occurs by interfer-
ence with antigen presentation, MHC restriction, CTL interactions betweeneach virus and the particulardiffer-
entiated cell(s) it infects rather than a conveniently avail-activation, and/or CTL activity (reviewed by Furth et al.,
1996). For example, human herpes simplex virus (HSV) able cell in the laboratory.
Biologically, adult mice persistently infected with theexpresses an immediate-early protein, IPC-47, that
blocks presentation of viral peptides to MHC class immunosuppressive variant exhibit a generalized and
not just a LCMV-specific immunodeficiency, since theyI–restricted CTL. IPC-47 binds TAP, a protein transporter
normally responsible for translocating thecytosolic pep- fail to mount efficient immune responses to other vi-
ruses, parasites, or tumors. The mechanism involved istide to the endoplasmic reticulum (ER) where MHC mole-
cules are synthesized (Furth et al., 1996; Hill et al., 1995). preferred replication of this immunosuppressive variant
in follicular interdigitating dendritic (professional anti-Human cytomegalovirus (HCMV) uses a series of differ-
ent genes, unique short (US) 2 and 11, to rapidly degrade gen-presenting) cells and in the spleen and lymph
nodes, as well as persistent infection of T lymphocytesthe MHC complex, presumably by shunting the MHC
complex back out into the cytosol for degradation by and macrophages. By contrast, the parental ARM strain
replicates preferentially in F4/801 macrophages in theproteosomes (Furth et al., 1996; Wiertz et al., 1996).
Although HSV and HCMV studies are elegant biochemi- red pulp of the spleen (Borrow et al., 1995). Hence,
the tropism of the immunosuppressive LCMV variant incally, the role of these viral genes in persistent infection
should be interpreted cautiously until there is evidence CD41 T cells and macrophages, involvement of profes-
sional antigen-presenting dendritic cells, and the resul-that they reproduce their in vitro effect in vivo and in
cells where they usually persist in (HSV/neurons, HCMV/ tant generalized immunosuppression closely mimic
events typical of HIV infection. The causes of this immu-monocyte-macrophages, and lymphocytes). The ade-
novirus A2 E3 gene complex contains and encodes a nosuppression is destruction of the virus-infected den-
dritic cells by CD81 LCMV CTL (Borrow et al., 1995),gp19 molecule, the carboxy terminus of which contains
a sequence motif that binds to MHC class I molecules the same immunopathologic process postulated for HIV
infection (Hayes et al., 1996).and retains them in the ER (Furth et al., 1996; Jackson
et al., 1990). Disturbances in antigen presentation by What is the consequence to a differentiated cell once
occupiedby a virus that persists? In one example, inocu-the adenovirus E3 gene complex have been observed
both in vitro (Furth et al., 1996; Jackson et al., 1990) and lation of newborn C3H/St mice with LCMV ARM leads
to persistent infection during which the virus replicatesin vivo (Efrat et al., 1995). LCMV persists in vivo by two
distinct mechanisms. First, mice infected neonatally or in growth hormone (GH)-producing cells of the pituitary
gland’s anterior lobe (Borrow and Oldstone, 1996). Al-in utero with LCMV become persistently infected for life
because such animals are unable to mount an effective though no structural abnormality of such GH-producing
cells is evident in vivo, the transcription of GH decreasesantiviral CTL response as virus replicates in the thymus
and specifically deletes (negative selection) LCMV-reac- approximately 16-fold with a resultant 5-fold reduction
in GH mRNA and a 2-fold reduction in the synthesis oftive T cells (King et al., 1992; Pircher et al., 1989).
Second, in such persistently infected mice, LCMV GH. The outcome is that the infected mouse fails to
grow and develop, becomes hypoglycemic, and conse-variants are generated and selected for replication in
lymphocytes and macrophages (Ahmed and Oldstone, quently dies within 30 days.
How does this GH deficiency occur? What roles do1988). Unlike the wild-type parental virus, these variants,
when inoculated into immunocompetent adult mice viral genes play? Experiments to answer these ques-
tions were based on the fact that LCMV ARM causescause persistent infection. In contrast, similar inocula-
tion of the parental virus generates LCMV-specific CTL GH disease in C3H/St mice, but other LCMV strains like
WE do not. LCMV has a bisegmented negative-strandedand clears the virus so that neither persistent infection
nor immunosuppression occurs. Genetic and biochemi- genome consisting of two species of single-stranded
RNA, designated L (large) and S (small). S RNA encodescal analysis to compare the parental Armstrong-strain
(ARM) virus and its progeny immunosuppressive vari- the virus GP and nucleoprotein (NP), while L RNA en-
codes the viral polymerase (L) and a small protein (Z)ants (like Clone 13) revealed a Phe (wild-type) to Leu
(immunosuppressive variant) change at amino acid 260 with an as yet unknown function but containing a zinc-
binding motif. Reassortants between LCMV ARM Cloneof the viral glycoprotein (GP) as a marker for both classes
of virus. Although several mutations occur in the ge- 53b (GH1) and WE Clone 54 (GHnil) map the GH disease
syndrome to genes encoded on the S RNA, i.e., the GPnome, this one is always associated with virus-induced
immunosuppression. As early as three to five weeks or NP. To focus on the role of the viral GP and/or NP
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genes, advantage was taken of observations from RNA Studies from this and other models highlight a number
of general principles. First, most viruses that persistviruses in which the high frequency of mutations oc-
curring during replication created heterogeneous mix- probably do so by impairing either antigen presentation
or CTL recognition. Hence, studies of persistent infec-tures of genetically closely-related genomes. Clones
picked from a WE 54 (GHnil)mixture of such quasispecies tions are likely to prove of value in dissecting the biology
of both these pathways. Second, it is possible in vivorevealed that over 95% showed the same phenotype as
the parental WE 54 clone in that they failed to cause and in vitro to manipulate viral genes to determine which
ones are involved in specific diseases and how theyGH disease. However, 5% of the isolated clones caused
GH disease. Reassortants between a WE 54 clone that produce their effects. This strategy has been used suc-
cessfully with several viruses. Unfortunately, space limi-caused GH disease and those that did not mapped the
defect to the S RNA. Sequencing showed that the NP tations in this review preclude discussion of similar anal-
yses for host gene expression, gene knockout mice, orstructure was conserved among the WE isolates but
that mutations in the GP gene product at amino acid polymorphic microsatellites distributed along chromo-
somes used to map effects by host genes. Third, it is153 caused a change from Ser to Phe. Interestingly this
mutation occurred in the part of GP that has been impli- now clear that, in addition to causing the GH syndrome
presented here, viruses that persist can alter the func-cated in binding to the LCMV receptor, suggesting that
the defect in GP (WE 54 [GHnil]) may be at the level of tion of the other differentiated cells in vivo including
neurons, other endocrine cells, and cells of the immunereceptor binding. To determine whether the NP gene
from WE 54 (GHnil) and ARM (GH1), once inside GH- system. Recent evidence indicates that, in several in-
stances, antiviral therapies can restore normalcy andforming cells, participated in the GH deficiency, two
approaches were used. In the first, vaccinia recombi- correct such diseases. Since we humans are continually
bathed in a sea of microbes, yet harmed by relativelynants were made that encoded LCMV ARM GP, NP, or
non-LCMV genes. Such studies showed that LCMV NP, few, persistence by viruses is likely to be a common
event, and viruses are likely to be responsible for a widebut not GP or the non-LCMV genes, disordered GH tran-
scription in appropriately transfected cells. The second variety of illnesses whose cause is currently unknown.
approach was construction of a transgenic mouse
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without killing it, an opportunity is available to reverse
the disease by use of antiviral therapy (de la Torre and
Oldstone, 1992). Accordingly, ribavirin, an antiviral agent
that is effective against several arenaviruses, the family
to which LCMV belongs, not only clears virus from in-
fected pituitary cells, but restores the GH-synthesizing
complex to normal in treated cells.
